Annual CFF
$485.67 M
+$482.45 M+14996.89%
November 30, 2024
Summary
- As of February 8, 2025, NRIX annual cash flow from financing activities is $485.67 million, with the most recent change of +$482.45 million (+14996.89%) on November 30, 2024.
- During the last 3 years, NRIX annual CFF has risen by +$331.79 million (+215.61%).
- NRIX annual CFF is now at all-time high.
Performance
NRIX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$200.52 M
+$154.75 M+338.11%
November 30, 2024
Summary
- As of February 8, 2025, NRIX quarterly cash flow from financing activities is $200.52 million, with the most recent change of +$154.75 million (+338.11%) on November 30, 2024.
- Over the past year, NRIX quarterly CFF has increased by +$198.90 million (+12247.35%).
- NRIX quarterly CFF is now -15.66% below its all-time high of $237.75 million, reached on May 31, 2024.
Performance
NRIX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$485.67 M
+$200.51 M+70.32%
November 30, 2024
Summary
- As of February 8, 2025, NRIX TTM cash flow from financing activities is $485.67 million, with the most recent change of +$200.51 million (+70.32%) on November 30, 2024.
- Over the past year, NRIX TTM CFF has increased by +$482.31 million (+14354.38%).
- NRIX TTM CFF is now at all-time high.
Performance
NRIX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NRIX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | +10000.0% | +10000.0% |
| 3 y3 years | +215.6% | +10000.0% | +314.4% |
| 5 y5 years | +10000.0% | +10000.0% | +314.4% |
NRIX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -15.7% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -15.7% | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -15.7% | >+9999.0% | at high | >+9999.0% |
Nurix Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | $485.67 M(>+9900.0%) | $200.52 M(+338.1%) | $485.67 M(+70.3%) |
| Aug 2024 | - | $45.77 M(-80.7%) | $285.15 M(+18.3%) |
| May 2024 | - | $237.75 M(>+9900.0%) | $241.09 M(+7075.2%) |
| Feb 2024 | - | $1.62 M(>+9900.0%) | $3.36 M(+4.4%) |
| Nov 2023 | $3.22 M(-97.3%) | $7000.00(-99.6%) | $3.22 M(+4.6%) |
| Aug 2023 | - | $1.70 M(+6716.0%) | $3.08 M(-97.4%) |
| May 2023 | - | $25.00 K(-98.3%) | $116.78 M(-0.3%) |
| Feb 2023 | - | $1.48 M(-1197.0%) | $117.19 M(-0.0%) |
| Nov 2022 | $117.19 M | -$135.00 K(-100.1%) | $117.19 M(-0.5%) |
| Aug 2022 | - | $115.41 M(>+9900.0%) | $117.83 M(+2866.4%) |
| May 2022 | - | $432.00 K(-71.0%) | $3.97 M(-97.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2022 | - | $1.49 M(+197.6%) | $154.01 M(+0.1%) |
| Nov 2021 | $153.88 M(-54.6%) | $500.00 K(-67.8%) | $153.88 M(+1.1%) |
| Aug 2021 | - | $1.55 M(-99.0%) | $152.26 M(-59.0%) |
| May 2021 | - | $150.47 M(>+9900.0%) | $371.12 M(+9.0%) |
| Feb 2021 | - | $1.36 M(-220.7%) | $340.34 M(+0.4%) |
| Nov 2020 | $339.02 M(>+9900.0%) | -$1.13 M(-100.5%) | $339.02 M(-0.3%) |
| Aug 2020 | - | $220.42 M(+84.2%) | $340.15 M(+184.1%) |
| May 2020 | - | $119.68 M(>+9900.0%) | $119.73 M(>+9900.0%) |
| Feb 2020 | - | $46.00 K | $46.00 K |
| Nov 2019 | $126.00 K(-76.2%) | - | - |
| Nov 2018 | $529.00 K | - | - |
FAQ
- What is Nurix Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Nurix Therapeutics?
- What is Nurix Therapeutics annual CFF year-on-year change?
- What is Nurix Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Nurix Therapeutics?
- What is Nurix Therapeutics quarterly CFF year-on-year change?
- What is Nurix Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Nurix Therapeutics?
- What is Nurix Therapeutics TTM CFF year-on-year change?
What is Nurix Therapeutics annual cash flow from financing activities?
The current annual CFF of NRIX is $485.67 M
What is the all time high annual CFF for Nurix Therapeutics?
Nurix Therapeutics all-time high annual cash flow from financing activities is $485.67 M
What is Nurix Therapeutics annual CFF year-on-year change?
Over the past year, NRIX annual cash flow from financing activities has changed by +$482.45 M (+14996.89%)
What is Nurix Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of NRIX is $200.52 M
What is the all time high quarterly CFF for Nurix Therapeutics?
Nurix Therapeutics all-time high quarterly cash flow from financing activities is $237.75 M
What is Nurix Therapeutics quarterly CFF year-on-year change?
Over the past year, NRIX quarterly cash flow from financing activities has changed by +$198.90 M (+12247.35%)
What is Nurix Therapeutics TTM cash flow from financing activities?
The current TTM CFF of NRIX is $485.67 M
What is the all time high TTM CFF for Nurix Therapeutics?
Nurix Therapeutics all-time high TTM cash flow from financing activities is $485.67 M
What is Nurix Therapeutics TTM CFF year-on-year change?
Over the past year, NRIX TTM cash flow from financing activities has changed by +$482.31 M (+14354.38%)